Restricted T-cell epitope diversity in the circumsporozoite protein from Plasmodium falciparum populations prevalent in Iran. 2007
aorchid: further evidence that CSP is genetically restricted
Malaria vaccines: the stage we are at. 2007
aorchid: review by adrian
Measurement of malaria vaccine efficacy in phase III trials: Report of a WHO consultation. 2007
aorchid: consensus that ineffective vaccines may be ok to use; must integrate with EPI schedule (already known)
A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults. 2007
aorchid: lyophilized AS02A ok. (already known)
Allelic dimorphism-associated restriction of recombination in Plasmodium falciparum msp1. 2007
aorchid: recombination with vaccine targets
Real-time PCR versus conventional PCR for malaria parasite detection in low-grade parasitemia. 2007
aorchid: better real-time pcr diagnosis; clinical trials; northern dx
The significance of third-generation HCV RIBA-indeterminate, RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays. 2004
aorchid: testing, RIBA, indeterminant
Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia. 2003
aorchid: clinical dhps mutations and resistance
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. 2004
aorchid: pcp dhps point mutations
Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. 2004
aorchid: pcp and dhps point mutations